Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
3
×
life sciences
national blog main
3
×
boston blog main
boston top stories
fda
national top stories
new york blog main
alirocumab
alnylam pharmaceuticals
amgen
boston
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
daniel o'day
detroit
detroit blog main
detroit top stories
evolocumab
foundation medicine
foundationone cdx
foundationone heme
genentech
inclisiran
medical devices
new york
new york top stories
novartis
osimertinib
pcsk9
pcsk9 inhibitors
regenerative medicine
regeneron pharmaceuticals
rna interference
roche
rucaparib (rubraca)
What
acquire
3
×
billion
3
×
agreed
cash
deal
adds
big
brings
broad
cholesterol
company
compound
confidence
device
didn’t
drug
extremities
fda
foundation
gain
genentech
giant
medco
medical
medicine
medicines
momentum
morning
new
novartis
panels
pay
pays
picked
poised
presence
profiling
ready
recently
redux
Language
unset
Current search:
deals
×
billion
×
" national blog main "
×
acquire
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine